No In Vitro Effects of Fatty Acids on Glucose Uptake, Lipolysis or Insulin Signaling in Rat Adipocytes

Abstract

Elevated plasma levels of free fatty acids (FFA) can produce insulin resistance in skeletal muscle tissue and liver and, together with alterations in β-cell function, this has been referred to as lipotoxicity. This study explores the effects of FFAs on insulin action in rat adipocytes. Cells were incubated 4 or 24 h with or without an unsaturated FFA, oleate or a saturated FFA, palmitate (0.6 and 1.5 mM, respectively). After the culture period, cells were washed and insulin effects on glucose uptake and lipolysis as well as cellular content of insulin signaling proteins (IRS-1, PI3-kinase, PKB and phosphorylated PKB) and the insulin regulated glucose transporter GLUT4 were measured. No significant differences were found in basal or insulin-stimulated glucose uptake in FFA-treated cells compared to control cells, regardless of fatty acid concentration or incubation period. Moreover, there were no significant alterations in the expression of IRS-1, PI3-kinase, PKB and GLUT4 following FFA exposure. Insulin’s ability to stimulate PKB phosphorylation was also left intact. Nor did we find any alterations following FFA exposure in basal or cAMP-stimulated lipolysis or in the ability of insulin to inhibit lipolysis. The results indicate that oleate or palmitate does not directly influence insulin action to stimulate glucose uptake and inhibit lipolysis in rat fat cells. Thus, lipotoxicity does not seem to occur in the fat tissue itself.

Glucose transport - Rat adipocytes - Oleate - Palmitate

References

• 1 Gordon E. Non-Esterified Fatty Acids in the Blood of Obese and Lean Subjects.  Am J Clin Nutr. 1960;  8 740-747
• 2 Reaven G M, Hollenbeck C, Jeng C Y, Wu M S, Chen Y D. Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM.  Diabetes. 1988;  37 1020-1024
• 3 Belfrage P, Fredrikson G, Nilsson N O, Stralfors P. Regulation of adipose-tissue lipolysis by phosphorylation of hormone-sensitive lipase.  Int J Obes. 1981;  5 635-641
• 4 Smith C J, Manganiello V C. Role of hormone-sensitive low Km cAMP phosphodiesterase in regulation of cAMP-dependent protein kinase and lipolysis in rat adipocytes.  Mol Pharmacol. 1989;  35 381-386
• 5 Degerman E, Belfrage P, Manganiello V C. Structure, localization, and regulation of cGMP-inhibited phosphodiesterase (PDE3).  J Biol Chem. 1997;  272 6823-6826
• 6 Holman G D, Kasuga M. From receptor to transporter: insulin signalling to glucose transport.  Diabetologia. 1997;  40 991-1003
• 7 Boden G, Jadali F. Effects of lipid on basal carbohydrate metabolism in normal men.  Diabetes. 1991;  40 686-692
• 8 Boden G, Chen X. Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes.  J Clin Invest. 1995;  96 1261-1268
• 9 Roden M, Price T B, Perseghin G, Petersen K F, Rothman D L, Cline G W, Shulman G I. Mechanism of free fatty acid-induced insulin resistance in humans.  J Clin Invest. 1996;  97 2859-2865
• 10 Thompson A L, Lim-Fraser M Y, Kraegen E W, Cooney G J. Effects of individual fatty acids on glucose uptake and glycogen synthesis in soleus muscle in vitro.  Am J Physiol Endocrinol Metab. 2000;  279 E577-584
• 11 Svedberg J, Bjorntorp P, Smith U, Lonnroth P. Free-fatty acid inhibition of insulin binding, degradation, and action in isolated rat hepatocytes.  Diabetes. 1990;  39 570-574
• 12 Rebrin K, Steil G M, Mittelman S D, Bergman R N. Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs.  J Clin Invest. 1996;  98 741-749
• 13 Boden G. Free fatty acids (FFA), a link between obesity and insulin resistance.  Front Biosci. 1998;  3 D169-175
• 14 Sako Y, Grill V E. A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and B cell oxidation through a process likely coupled to fatty acid oxidation.  Endocrinology. 1990;  127 1580-1589
• 15 Paolisso G, Gambardella A, Amato L, Tortoriello R, D'Amore A, Varricchio M, D'Onofrio F. Opposite effects of short- and long-term fatty acid infusion on insulin secretion in healthy subjects.  Diabetologia. 1995;  38 1295-1299
• 16 Zhou Y P, Grill V. Long term exposure to fatty acids and ketones inhibits B-cell functions in human pancreatic islets of Langerhans.  J Clin Endocrinol Metab. 1995;  80 1584-1590
• 17 Carpentier A, Mittelman S D, Lamarche B, Bergman R N, Giacca A, Lewis G F. Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation.  Am J Physiol. 1999;  276 E1055-1066
• 18 Randle P, Garland P, Hales C, Newsholme E. The glucose fatty acid cycle: it's role in insulin sensitivity and the metabolic disturbances of diabetes mellitus.  Lancet. 1963;  1 785-789
• 19 Dresner A, Laurent D, Marcucci M, Griffin M E, Dufour S, Cline G W, Slezak L A, Andersen D K, Hundal R S, Rothman D L, Petersen K F, Shulman G I. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity.  J Clin Invest. 1999;  103 253-259
• 20 Griffin M E, Marcucci M J, Cline G W, Bell K, Barucci N, Lee D, Goodyear L J, Kraegen E W, White M F, Shulman G I. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade.  Diabetes. 1999;  48 1270-1274
• 21 Eriksson J W, Smith U, Waagstein F, Wysocki M, Jansson P A. Glucose turnover and adipose tissue lipolysis are insulin-resistant in healthy relatives of type 2 diabetes patients: is cellular insulin resistance a secondary phenomenon?.  Diabetes. 1999;  48 1572-1578
• 22 Hardy R W, Ladenson J H, Henriksen E J, Holloszy J O, McDonald J M. Palmitate stimulates glucose transport in rat adipocytes by a mechanism involving translocation of the insulin sensitive glucose transporter (GLUT4).  Biochem Biophys Res Commun. 1991;  177 343-349
• 23 Usui I, Haruta T, Takata Y, Iwata M, Uno T, Takano A, Ueno E, Ishibashi O, Ishihara H, Wada T, Sasaoka T, Kobayashi M. Differential effects of palmitate on glucose uptake in rat-1 fibroblasts and 3T3-L1 adipocytes.  Horm Metab Res. 1999;  31 546-552
• 24 Hunnicutt J W, Hardy R W, Williford J, McDonald J M. Saturated fatty acid-induced insulin resistance in rat adipocytes.  Diabetes. 1994;  43 540-545
• 25 Van Epps-Fung M, Williford J, Wells A, Hardy R W. Fatty acid-induced insulin resistance in adipocytes.  Endocrinology. 1997;  138 4338-4345
• 26 Rustan A C, Solberg R, Reseland J E, Andersen M H, Drevon C A, Aas V. Fatty acids modulate leptin and leptin receptor (OB-Rb) gene expression and leptin secretion in cultured human skeletal muscle cells.  Diabetologia. 2002;  45 Suppl 2 A59-A60 (Abstract)
• 27 Thalén P, Frangioudakis G, Camejo G, Furler S, Kraegen E, Ljung B, Oakes N. Contribution of circulating triglyceride to fatty acid loading in individual tissues in vivo.  Diabetes. 2003;  52 (Suppl 1) A9 (abstract)
• 28 Smith U, Sjostrom L, Bjorntorp P. Comparison of two methods for determining human adipose cell size.  J Lipid Res. 1972;  13 822-824
• 29 Buren J, Liu H X, Jensen J, Eriksson J W. Dexamethasone impairs insulin signalling and glucose transport by depletion of insulin receptor substrate-1, phosphatidylinositol 3-kinase and protein kinase B in primary cultured rat adipocytes.  Eur J Endocrinol. 2002;  146 419-429
• 30 Kashiwagi A, Verso M A, Andrews J, Vasquez B, Reaven G, Foley J E. In vitro insulin resistance of human adipocytes isolated from subjects with noninsulin-dependent diabetes mellitus.  J Clin Invest. 1983;  72 1246-1254
• 31 Buren J, Liu H X, Lauritz J, Eriksson J W. High glucose and insulin in combination cause insulin receptor substrate-1 and -2 depletion and protein kinase B desensitisation in primary cultured rat adipocytes: possible implications for insulin resistance in type 2 diabetes.  Eur J Endocrinol. 2003;  148 157-167
• 32 Lindmark S, Wiklund U, Bjerle P, Eriksson J W. Does the autonomic nervous system play a role in the development of insulin resistance? A study on heart rate variability in first-degree relatives of Type 2 diabetes patients and control subjects.  Diabet Med. 2003;  20 399-405